Home > Insider Trading > Filing (0001140361-15-044057)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1416792	Relypsa Inc	RLYP	Pharmaceutical Preparations (2834)	260893742

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1455189	Lance Berman	C/O Relypsa, Inc. 100 Cardinal Way Redwood City CA 94063	Chief Medical Officer And Svp	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-12-07	13,896	$3.96	35,186	No	4	M	Direct
Common Stock	Acquisiton	2015-12-07	11,349	$3.96	46,535	No	4	M	Direct
Common Stock	Acquisiton	2015-12-07	4,755	$7.40	51,290	No	4	M	Direct
Common Stock	Disposition	2015-12-07	30,000	$29.78	21,290	No	4	S	Direct
Common Stock	Acquisiton	2015-12-09	750	$7.40	22,040	No	4	M	Direct
Common Stock	Disposition	2015-12-09	750	$29.50	21,290	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-12-07	13,896	$0.00	13,896	$3.96
Common Stock	Stock Option (right to buy)	Disposition	2015-12-07	11,349	$0.00	11,349	$3.96
Common Stock	Stock Option (right to buy)	Disposition	2015-12-07	4,755	$0.00	4,755	$7.40
Common Stock	Stock Option (right to buy)	Disposition	2015-12-09	750	$0.00	750	$7.40

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,668	2021-12-13	No	4	M	Direct
21,765	2022-09-27	No	4	M	Direct
26,164	2023-07-23	No	4	M	Direct
25,414	2023-07-23	No	4	M	Direct

Footnotes

Includes 20,125 restricted stock units.
The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from December 9, 2011 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from September 19, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from July 24, 2013 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.